As Illinois’ medical marijuana industry ramps up, regulatory officials are preparing to start following medical cannabis throughout the supply chain.
The state recently inked a $724,000, three-year contract with BioTrack THC to help track marijuana electronically from the cultivation stage until it’s sold to patients, according to the Chicago Sun-Times. State records show that the contract starts in August, the newspaper reported.
It’s yet another step forward for a program that has stumbled multiple times and experienced several delays since the state legalized medical cannabis in 2013.
Ross Morreale – the chief compliance officer for Ataraxia, which received final authorization to begin cultivation on July 10 – told the Sun-Times that the company will have oil-based products before flower because it must let buds dry and cure, a step that can be skipped when producing oils.